Valeriane Leroy
0000-0003-3542-8616
Inserm, Université Paul Sabatier Toulouse III
209 papers found
Refreshing results…
Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study
Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency.
IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development
Inequality in outcomes for adolescents living with perinatally acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis
Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies
Challenges and perspectives of compliance with pediatric antiretroviral therapy in Sub-Saharan Africa
The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis
Evaluation of a Nutritional Support Intervention in Malnourished HIV-Infected Children in Bamako, Mali:
Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old
Transition from paediatric to adult care of adolescents living with HIV in sub-Saharan Africa: challenges, youth-friendly models, and outcomes
Inequality in mortality and access to antiretroviral therapy in adolescents living with perinatally acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) cohort collaboration analysis
Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort
High dose of efavirenz (25 mg/kg) in children under 3 years old
Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines
Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
Contribution of maternal ART and breastfeeding to 24-month survival in HIV-exposed uninfected children: an individual pooled analysis of African and Asian studies
Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium
Taking a critical look at the UNAIDS global estimates on paediatric and adolescent HIV survival and death
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Cote d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial
Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d’Ivoire
Missing publications? Search for publications with a matching author name.